Amit Hasija

Insider Reports History

Location
Montreal, Quebec, Canada
Signature
/s/ Joseph Oliveto, Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Amit Hasija:

Company Role Class Num Shares Value Price $ Report Date Ownership
Milestone Pharmaceuticals Inc. CFO & EVP of Corp. Development Common Shares 99,848 $192,706 $1.93 26 Jan 2026 Direct
Milestone Pharmaceuticals Inc. CFO & EVP of Corp. Development Employee Stock Option (right to buy) 204,000 02 Feb 2026 Direct
Milestone Pharmaceuticals Inc. CFO & EVP of Corp. Development Restricted Stock Unit 136,000 02 Feb 2026 Direct
Milestone Pharmaceuticals Inc. CFO & EVP of Corp. Development Restricted Stock Units 60,300 26 Jan 2026 Direct
Milestone Pharmaceuticals Inc. CFO & EVP of Corp. Development Series A Common Warrants (right to buy) 50,000 11 Jul 2025 Direct
Milestone Pharmaceuticals Inc. CFO & EVP of Corp. Development Series B Common Warrants (right to buy) 50,000 11 Jul 2025 Direct

Insider Reports Filed by Amit Hasija

Symbol Company Period Transactions Value $ Form Type Role Filing Time
MIST Milestone Pharmaceuticals Inc. 02 Feb 2026 1 $0 4/A CFO & EVP of Corp. Development 05 Feb 2026, 16:30
MIST Milestone Pharmaceuticals Inc. 12 Dec 2025 6 -$158,209 4 CFO & EVP of Corp. Development 28 Jan 2026, 18:30
MIST Milestone Pharmaceuticals Inc. 11 Jul 2025 3 $0 4 CFO & EVP of Corp. Development 15 Jul 2025, 16:15
MIST Milestone Pharmaceuticals Inc. 27 Jan 2025 2 $0 4 CFO & EVP of Corp. Development 29 Jan 2025, 16:15
MIST Milestone Pharmaceuticals Inc. 16 Feb 2023 1 $0 4 CFO & EVP of Corp. Development 17 Feb 2023, 15:51
MIST Milestone Pharmaceuticals Inc. 21 Mar 2022 1 $0 4 CFO & EVP of Corp. Development 23 Mar 2022, 21:47